China's decision to sentence the former head of its State Food and Drug Administration to death for taking bribes is seen as an indication of pressure the country feels over its drug approvals. The government already had promised stronger oversight of drug production before the former official's just-completed trial, which centered on at least $850,000 worth of bribes by eight unnamed drugmakers.

Related Summaries